Xing Jin

发表

miR-6077 promotes cisplatin/pemetrexed resistance in lung adenocarcinoma via CDKN1A/cell cycle arrest and KEAP1/ferroptosis pathways

C. Zhan, Qun Wang, L. Tan, 2022, Molecular therapy. Nucleic acids.

Comprehensive Genome-Scale Analysis of Esophageal Carcinoma With Esophageal Tissue-Resident Micro-Environment Discrepancy

Jie Gu, Chunlai Lu, D. Ge, 2022, Frontiers in Microbiology.

A Novel Prognostic Signature Revealed the Interaction of Immune Cells in Tumor Microenvironment Based on Single-Cell RNA Sequencing for Lung Adenocarcinoma

Zhenyu Liao, Zhenyu Liao, Yu Shi, 2022, Journal of immunology research.

The comparison of Lobe-Specific or Systematic Mediastinal Lymph Node Dissection for Early-Stage Lung Adenocarcinoma With Consolidation Tumor Ratio Over 0.5.

Wei Jiang, Qun Wang, Zhencong Chen, 2022, Clinical lung cancer.

Weighted Correlation Network Analysis of Cancer Stem Cell-Related Prognostic Biomarkers in Esophageal Squamous Cell Carcinoma

C. Zhan, Qun Wang, Zhencong Chen, 2022, Technology in cancer research & treatment.

Pan-Driver-Negatives versus Epidermal Growth Factor Receptor Mutants for C-Stage IA Lung Adenocarcinoma with Ground-Glass Opacity

C. Zhan, Qun Wang, Jianrong Zhang, 2022, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

Identification and validation of the mitochondrial function related hub genes by unsupervised machine learning and multi-omics analyses in lung adenocarcinoma

C. Zhan, Miao Lin, Zhencong Chen, 2022, Heliyon.

Integrated analysis of patients with KEAP1/NFE2L2/CUL3 mutations in lung adenocarcinomas

Songtao Xu, Guoshu Bi, Zhencong Chen, 2021, Cancer medicine.

Signatures of malignant cells and novel therapeutic targets revealed by single‐cell sequencing in lung adenocarcinoma

C. Zhan, Qun Wang, Guoshu Bi, 2022, Cancer medicine.

Tumor-Associated Regulatory T Cells in Non-Small-Cell Lung Cancer: Current Advances and Future Perspectives

Guoshu Bi, Jiaqi Liang, Yunyi Bian, 2022, Journal of immunology research.

Tissue‐resident CXCR4+ macrophage as a poor prognosis signature promotes pancreatic ductal adenocarcinoma progression

Wei Wu, Tianjiao Li, Longyun Ye, 2023, International journal of cancer.

Dissecting the single-cell transcriptome network of macrophage and identifies a signature to predict prognosis in lung adenocarcinoma

C. Zhan, Qun Wang, Weifeng Hong, 2023, Cellular Oncology.

Ground glass nodules with scattered or eccentric island‐shaped consolidations may have poor outcomes

C. Zhan, Qun Wang, L. Tan, 2023, Cancer Innovation.

The genomic signature of resistance to platinum-containing neoadjuvant therapy based on single-cell data

C. Zhan, Zongwu Lin, Qun Wang, 2023, Cell & Bioscience.

ARNTL2 is an indicator of poor prognosis, promotes epithelial-to-mesenchymal transition and inhibits ferroptosis in lung adenocarcinoma

C. Zhan, Qun Wang, Hao Wang, 2022, Translational oncology.

AGRN promotes lung adenocarcinoma progression by activating Notch signaling pathway and acts as a therapeutic target.

C. Zhan, Qun Wang, Guoshu Bi, 2023, Pharmacological research.

Comments on Surgeon-Patient Sex Concordance and Postoperative Outcomes.

C. Zhan, Qun Wang, Xing Jin, 2022, JAMA surgery.

Inhibition of PKA/CREB1 pathway confers sensitivity to ferroptosis in non-small cell lung cancer

C. Zhan, Guoshu Bi, Zhengyang Hu, 2023, Respiratory Research.

Polyamine-mediated ferroptosis amplification acts as a targetable vulnerability in cancer

C. Zhan, Guoshu Bi, Zhencong Chen, 2024, Nature communications.

IL6-STAT3-C/EBPβ-IL6 positive feedback loop in tumor-associated macrophages promotes the EMT and metastasis of lung adenocarcinoma

Dejun Zeng, C. Zhan, Zongwu Lin, 2024, Journal of experimental & clinical cancer research : CR.

Targeting TAM-secreted S100A9 effectively enhances the tumor-suppressive effect of metformin in treating lung adenocarcinoma.

C. Zhan, Zongwu Lin, Qun Wang, 2023, Cancer letters.